Skip to main content
logo
Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.5151
-0.0275 (-5.07%)
At close: May 15, 2026, 4:00 PM EDT
0.5199
+0.0048 (0.93%)
Pre-market: May 18, 2026, 7:00 AM EDT

Werewolf Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--1.8919.9416.4-
Revenue Growth (YoY)
---90.55%21.60%--
Gross Profit
--1.8919.9416.4-
Selling, General & Admin
16.0715.8519.0518.6718.714.82
Research & Development
39.8944.8356.4341.7853.7635.27
Total Operating Expenses
55.9660.6875.4860.4572.4650.09
Operating Income
-55.96-60.68-73.59-40.5-56.06-50.09
Interest Income
2.543.116.677.421.910.1
Interest Expense
-5.38-5.27-4.66-3.14--
Other Non-Operating Income (Expense)
1.181.884.141.992.580.1
Total Non-Operating Income (Expense)
-1.65-0.296.166.274.490.21
Pretax Income
-57.61-60.97-67.44-34.23-51.56-49.88
Net Income
-56.27-60.82-70.52-37.37-53.81-201.93
Net Income Attributable to Preferred Dividends
-----151.94
Net Income to Common
-56.27-60.82-70.52-37.37-53.81-201.93
Shares Outstanding (Basic)
474643362918
Shares Outstanding (Diluted)
474744362918
Shares Change (YoY)
6.97%6.73%23.04%23.50%56.40%1736.32%
EPS (Basic)
-1.21-1.32-1.63-1.05-1.86-10.94
EPS (Diluted)
-1.24-1.33-1.63-1.05-1.86-10.94
Shares Outstanding
48.648.644.8339.1131.4327.31
Free Cash Flow
-51.94-60.29-56.44-33.38-44.21-43.37
Free Cash Flow Per Share
-1.10-1.29-1.29-0.94-1.53-2.35
Gross Margin
--100.00%100.00%100.00%-
Operating Margin
---3904.19%-203.09%-341.78%-
Profit Margin
---3740.85%-187.37%-328.09%-
FCF Margin
---2994.27%-167.38%-269.54%-
EBITDA
-54.35-59.04-71.78-38.74-54.95-49.87
EBITDA Margin
---3807.96%-194.25%-335.05%-
EBIT
-55.96-60.68-73.59-40.5-56.06-50.09
EBIT Margin
---3904.19%-203.09%-341.78%-
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q